Skip to main content

Compare Stocks

Date Range: 

 Antares PharmaIntersect ENTInvo BioscienceOraSure TechnologiesVapotherm
SymbolNASDAQ:ATRSNASDAQ:XENTOTCMKTS:IVOBNASDAQ:OSURNYSE:VAPO
Price Information
Current Price$4.00$17.66$0.22$9.51$18.01
52 Week RangeBuyHoldN/ABuyBuy
MarketRank™
Overall Score1.81.70.51.71.5
Analysis Score3.53.20.03.43.5
Community Score2.82.82.62.82.3
Dividend Score0.00.00.00.00.0
Ownership Score0.81.70.01.71.7
Earnings & Valuation Score1.90.60.00.60.0
Analyst Ratings
Consensus RecommendationBuyHoldN/ABuyBuy
Consensus Price Target$5.75$25.00N/A$17.60$43.00
% Upside from Price Target43.75% upside41.56% upsideN/A85.07% upside138.76% upside
Trade Information
Market Cap$675.19 million$585.27 million$619.66 million$684.34 million$466.68 million
Beta1.441.34-0.810.04-1.5
Average Volume1,142,139204,56243,0361,071,912341,307
Sales & Book Value
Annual Revenue$123.86 million$109.14 million$490,000.00$154.60 million$48.10 million
Price / Sales5.455.3670.794.439.70
CashflowN/AN/AN/A$0.19 per shareN/A
Price / CashN/AN/AN/A50.78N/A
Book Value$0.33 per share$3.75 per share($0.02) per share$4.98 per share$2.55 per share
Price / Book12.124.71-11.001.917.06
Profitability
Net Income$-2,030,000.00$-42,990,000.00$-3,080,000.00$16.66 million$-51,060,000.00
EPS($0.01)($1.37)N/A$0.13($2.74)
Trailing P/E Ratio66.68N/AN/AN/AN/A
Forward P/E Ratio16.67N/A10.57N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins6.64%-71.96%-166.95%-9.05%-47.80%
Return on Equity (ROE)16.48%-55.81%N/A-3.51%-51.59%
Return on Assets (ROA)6.69%-40.23%-85.23%-3.13%-29.83%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.53%0.72%N/AN/A0.33%
Current Ratio2.47%11.28%1.05%8.14%5.96%
Quick Ratio2.08%10.29%1.02%7.32%5.13%
Ownership Information
Institutional Ownership Percentage39.92%84.32%N/A98.13%70.35%
Insider Ownership Percentage5.90%3.50%20.64%1.70%34.40%
Miscellaneous
Employees1854062570397
Shares Outstanding168.80 million33.14 million157.67 million71.96 million25.91 million
Next Earnings Date8/5/2021 (Estimated)8/3/2021 (Estimated)N/A8/4/2021 (Estimated)8/3/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable
SourceHeadline
Array Stock Could Rise in the Long Run Despite Near-Term Uncertainty, Says JP Morgan - Report DoorArray Stock Could Rise in the Long Run Despite Near-Term Uncertainty, Says JP Morgan - Report Door
reportdoor.com - May 15 at 9:18 AM
Heliox Market 2021-2026 Global Analysis : BOC Healthcare, Air Liquide Healthcare, Praxair Technology, HycompUSA, VAPOTHERM – Test & Measurement - Test & MeasurementHeliox Market 2021-2026 Global Analysis : BOC Healthcare, Air Liquide Healthcare, Praxair Technology, HycompUSA, VAPOTHERM – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 14 at 1:22 PM
Inflation Angst Sees Korean, Thai Bonds Looking Most Vulnerable - Report DoorInflation Angst Sees Korean, Thai Bonds Looking Most Vulnerable - Report Door
reportdoor.com - May 14 at 7:51 AM
High-flow Nasal Cannula Market to Witness Rapid Growth by 2027 | Vapotherm, Smiths Medical, ResMed – Test & Measurement - Test & MeasurementHigh-flow Nasal Cannula Market to Witness Rapid Growth by 2027 | Vapotherm, Smiths Medical, ResMed – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 13 at 1:26 PM
Ignore the Red Herring, Moderna Stock Is a Buy, Says Oppenheimer - Report DoorIgnore the Red Herring, Moderna Stock Is a 'Buy,' Says Oppenheimer - Report Door
reportdoor.com - May 13 at 8:26 AM
Musk Sends Bitcoin Tumbling With Shock U-Turn on Payments - Report DoorMusk Sends Bitcoin Tumbling With Shock U-Turn on Payments - Report Door
reportdoor.com - May 13 at 8:26 AM
Alibaba Targets 30% Revenue Growth After First Loss Since 2012 - Report DoorAlibaba Targets 30% Revenue Growth After First Loss Since 2012 - Report Door
reportdoor.com - May 13 at 8:26 AM
S&P 500 Price Forecast – Stock Markets Crater Again - Report DoorS&P 500 Price Forecast – Stock Markets Crater Again - Report Door
reportdoor.com - May 13 at 8:26 AM
Ignore the Red Herring, Moderna Stock Is a Buy, Says Oppenheimer – The Madison Leader Gazette - The Madison Leader GazetteIgnore the Red Herring, Moderna Stock Is a 'Buy,' Says Oppenheimer – The Madison Leader Gazette - The Madison Leader Gazette
wmleader.com - May 13 at 1:19 AM
American Airlines to resume non-stop service on two flights hit by fuel shortage - Yahoo FinanceAmerican Airlines to resume non-stop service on two flights hit by fuel shortage - Yahoo Finance
finance.yahoo.com - May 13 at 1:19 AM
Gold Price Prediction – Prices Decline on Stronger Inflation Figures as the Dollar Rises - Report DoorGold Price Prediction – Prices Decline on Stronger Inflation Figures as the Dollar Rises - Report Door
reportdoor.com - May 13 at 1:19 AM
Why Costco is secretly a winner from Colonial pipeline shutdown fueled gas lines – The Madison Leader Gazette - The Madison Leader GazetteWhy Costco is secretly a winner from Colonial pipeline shutdown fueled gas lines – The Madison Leader Gazette - The Madison Leader Gazette
wmleader.com - May 12 at 8:19 PM
3 Stocks That Are Flirting With a Bottom; Analysts Say ‘Buy’ - Yahoo Finance3 Stocks That Are Flirting With a Bottom; Analysts Say ‘Buy’ - Yahoo Finance
finance.yahoo.com - May 12 at 3:18 PM
Vapotherm (NYSE:VAPO) Releases FY 2021 Earnings GuidanceVapotherm (NYSE:VAPO) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 12 at 9:56 AM
Market Opportunities for High Flow Oxygen Cannula Industry by Fisher & Paykel Healthcare, Vapotherm, ResMed, Teleflex, Salter Labs, Flexicare, and more | Affluence – Clark County Blog - Clark County BlogMarket Opportunities for High Flow Oxygen Cannula Industry by Fisher & Paykel Healthcare, Vapotherm, ResMed, Teleflex, Salter Labs, Flexicare, and more | Affluence – Clark County Blog - Clark County Blog
clarkcountyblog.com - May 10 at 9:17 PM
Head to Head Comparison: Ophectra Real Estate and Investments (OTCMKTS:MTTCF) versus Vapotherm (NYSE:VAPO)Head to Head Comparison: Ophectra Real Estate and Investments (OTCMKTS:MTTCF) versus Vapotherm (NYSE:VAPO)
americanbankingnews.com - May 10 at 3:47 PM
Piper Sandler Weighs in on Vapotherm, Inc.s Q3 2021 Earnings (NYSE:VAPO)Piper Sandler Weighs in on Vapotherm, Inc.'s Q3 2021 Earnings (NYSE:VAPO)
americanbankingnews.com - May 10 at 2:50 AM
Q2 2021 Earnings Forecast for Vapotherm, Inc. (NYSE:VAPO) Issued By William BlairQ2 2021 Earnings Forecast for Vapotherm, Inc. (NYSE:VAPO) Issued By William Blair
americanbankingnews.com - May 10 at 1:14 AM
Vapotherm, Inc. (VAPO) CEO Joe Army on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaVapotherm, Inc. (VAPO) CEO Joe Army on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 9 at 1:21 AM
The Vapotherm, Inc. (NYSE:VAPO) First-Quarter Results Are Out And Analysts Have Published New Forecasts - NasdaqThe Vapotherm, Inc. (NYSE:VAPO) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Nasdaq
nasdaq.com - May 8 at 3:17 PM
Vapotherm Reports First Quarter 2021 Financial Results - Business WireVapotherm Reports First Quarter 2021 Financial Results - Business Wire
businesswire.com - May 7 at 9:26 AM
Vapotherm: Q1 Earnings Snapshot - Albany Times UnionVapotherm: Q1 Earnings Snapshot - Albany Times Union
timesunion.com - May 6 at 11:25 PM
Is Vapotherm Inc (VAPO) Stock a Smart Investment Thursday? - InvestorsObserverIs Vapotherm Inc (VAPO) Stock a Smart Investment Thursday? - InvestorsObserver
investorsobserver.com - May 6 at 6:24 PM
Vapotherm, Inc. (VAPO) Stock Poised to Recover Following Reports of Promising Q1 2021 Financials - Market GlobalistVapotherm, Inc. (VAPO) Stock Poised to Recover Following Reports of Promising Q1 2021 Financials - Market Globalist
marketglobalist.com - May 6 at 1:24 PM
Vapotherm to Participate in the Bank of America Securities 2021 Health Care Conference - Yahoo FinanceVapotherm to Participate in the Bank of America Securities 2021 Health Care Conference - Yahoo Finance
finance.yahoo.com - May 6 at 1:24 PM
DateCompanyBrokerageAction
5/10/2021Antares PharmaHC WainwrightBoost Price Target
10/1/2020Antares PharmaRaymond JamesReiterated Rating
6/21/2020Antares PharmaPiper SandlerReiterated Rating
6/21/2020Antares PharmaLADENBURG THALM/SH SHReiterated Rating
2/25/2019Antares PharmaCowenInitiated Coverage
11/6/2018Antares PharmaJefferies Financial GroupBoost Price Target
8/17/2018Antares PharmaPiper Jaffray CompaniesReiterated Rating
5/11/2021Intersect ENTSVB LeerinkLower Price Target
1/11/2021Intersect ENTCanaccord GenuityUpgrade
11/19/2020Intersect ENTBTIG ResearchUpgrade
10/8/2020Intersect ENTJPMorgan Chase & Co.Downgrade
8/7/2020Intersect ENTGuggenheimUpgrade
8/4/2020Intersect ENTOppenheimerReiterated Rating
4/15/2020Intersect ENTBank of AmericaDowngrade
5/6/2021OraSure TechnologiesLake Street CapitalLower Price Target
3/2/2021OraSure TechnologiesCitigroupLower Price Target
8/21/2020OraSure TechnologiesEvercore ISIInitiated Coverage
4/21/2020OraSure TechnologiesStephensInitiated Coverage
3/5/2020VapothermWilliam BlairReiterated Rating
(Data available from 5/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.